Trastuzumab Suppliers & Bulk Manufacturers

Available Forms: IV & SQ Injection

Available Strengths: IV : 150 mg/ 7.5 mL (vial); SQ: 600 mg/ 5 mL (syringe)

Reference Brands: Herceptin® (EU & US); Herceptin Hylecta® (subcutaneous formulation)

Category: Oncology Cancer Care

Trastuzumab is available in IV & SQ Injection and strengths such as IV : 150 mg/ 7.5 mL (vial); SQ: 600 mg/ 5 mL (syringe). Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Trastuzumab is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Trastuzumab can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description: Trastuzumab is a monoclonal antibody used in oncology, primarily for the treatment of HER2-positive breast cancer and gastric cancer. It works by targeting the HER2 receptor, a protein that is overexpressed in some cancer cells, blocking its signaling and inhibiting cancer cell growth. Available as Herceptin® in both the US and EU, Trastuzumab is offered in intravenous (IV) and subcutaneous (SC) formulations. The IV formulation is commonly administered in 150 mg vials, while the SC formulation is available in 600 mg syringes. Used as part of combination therapy, it improves patient outcomes in HER2-positive cancers.